| Hans-Günter Meyer-Thompson | Verschiedene
FDA alerts health care professionals of risks to patients exposed to xylazine in illicit drugs
FDA alerts health care professionals of risks to patients exposed to xylazine in illicit drugs
Health care professionals should be cautious of possible xylazine inclusion in fentanyl, heroin, and other illicit drug overdoses, as naloxone may not be able to reverse its effects. FDA is aware of increasing reports of serious side effects from individuals exposed to fentanyl, heroin, and other illicit drugs contaminated with xylazine. (FDA – US Food&Drug Administration, USA, 08.11.2022)
https://www.fda.gov/drugs/drug-safety-and-availability/fda-alerts-health-care-professionals-risks-patients-exposed-xylazine-illicit-drugs